Publication | Open Access

Apoptosis-based dual molecular targeting by INNO-406, a second-generation Bcr-Abl inhibitor, and ABT-737, an inhibitor of antiapoptotic Bcl-2 proteins, against Bcr-Abl-positive leukemia

Hematological MalignancyMixed-phenotype Acute LeukemiaMalignant Blood DisorderApoptosisImmunologyCell DeathApoptosis-based Dual MolecularBcr-abl-positive LeukemiaAntiapoptotic Bcl-2 ProteinsImmunotherapyMedicineCell BiologyCancer ResearchTumor BiologyDrug Discovery